Reply from Authors re: Jack A. Schalken. Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development. Eur Urol 2010;58:19-20

European Urology

Volumn 58, Issue 1, 2010, Pages 20-21

  Stephan, Carsten ^a,b   Jentzmik, Florian ^a   Jung, Klaus ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Berlin Institute for Urologic Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BIOLOGICAL MARKER; CREATININE; PROSTATE SPECIFIC ANTIGEN; SARCOSINE; TUMOR ANTIGEN;

ANALYTIC METHOD; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; EDITORIAL; FLUOROMETRY; FOOD AND DRUG ADMINISTRATION; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; METHODOLOGY; NON INVASIVE MEASUREMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REFERENCE VALUE; URINALYSIS;

EID: 77952883657     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.03.004     Document Type: Editorial

References (10)

1. Sreekumar A., Poisson L.M., Rajendiran T.M., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457 (2009) 910-914
2. Jentzmik F., Stephan C., Miller K., et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 58 (2010) 12-18
3. Schalken J.A. Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development. Eur Urol 58 (2010) 19-20
4. Bellon G., Lundy A.M., Malgras A., and Borel J.P. Fluorometric evaluation of sarcosine in urine and serum. J Chromatogr 311 (1984) 405-410
5. Bales J.R., Sadler P.J., Nicholson J.K., and Timbrell J.A. Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy. Clin Chem 30 (1984) 1631-1636
6. Deminice R., Portari G.V., Marchini J.S., Vannucchi H., and Jordao A.A. Effects of a low-protein diet on plasma amino acid and homocysteine levels and oxidative status in rats. Ann Nutr Metab 54 (2009) 202-207
7. Michael A., Stephan C., Kristiansen G., et al. Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation. Prostate 62 (2005) 34-39
8. Sokoll L.J., Ellis W., Lange P., et al. A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy. Clin Chim Acta 389 (2008) 1-6
9. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem 49 (2003) 7-18
10. Simera I., Moher D., Hoey J., Schulz K.F., and Altman D.G. A catalogue of reporting guidelines for health research. Eur J Clin Invest 40 (2010) 35-53